Unilateral transcranial photobiomodulation for opioid addiction in a clinical practice: A clinical overview and case series.
Unilateral transcranial photobiomodulation for opioid addiction in a clinical practice: A clinical overview and case series.
复制标题
临床实践中单侧经颅光生物调节治疗阿片类药物成瘾：临床概述和病例系列。
DOI：
10.1016/j.jpsychires.2020.12.004
复制
发表时间：
2021
影响因子：
4.8
通讯作者：
Schiffer,Fredric
中科院分区：
文献类型：
--
作者：
Schiffer,Fredric
阿片类药物使用障碍（OUD）给个人、家庭和社会带来巨大的功能障碍和痛苦。很少有好的治疗方法。本文提出了一种新的，易于应用，无痛，治疗，可以应用作为一种辅助的心理治疗和medications.MethodsThe作者提出了一个回顾性的概述和4个简短的病例报告。两个是典型的非常积极响应的患者，一个是积极但不显着响应的患者，一个是无响应的患者。作者使用单侧经颅光生物调节（UtPBM），近红外模式，适用于半球更积极的半球情绪效价（HEV）作为一种治疗，以增加患者的日常treatment.Results：病例报告是从42例连续患者在他的实践与OUD，他已经给了382治疗超过18个月，根据需要。作者的主观临床观察结果是，在42例患者中，26例（62%）持续对UtPBM产生反应（如病例报告中所述），患者和作者很容易观察到明显获益，8例（19%）有帮助，但反应不显著，8例（19%）无明显反应。这3个特征将通过临床实例进行说明。有没有副作用的报告或观察，除了2名妇女谁经历了焦虑，解决了与psychotherapy.ConclusionsUsing UtPBM作为一个deletive治疗的作者通常的深入的心理治疗和药物管理，他发现主观上，对于他的大多数病人，这种治疗是一个有价值的，安全的好处，他们的治疗OUD。
IntroductionOpioid Use Disorders (OUD) cause great disfunction and pain to individuals, families, and societies. There are few good treatments. This paper presents a novel, easily applied, painless, therapy that can be applied as an adjunct to psychotherapies and medications.MethodsThe author presents a retrospective overview and 4 brief case reports. Two are typical of very positively responsive patients, one is of a positively but not remarkably responsive patient, and one of a non-responsive patient. The author used unilateral transcranial photobiomodulation (UtPBM), near infrared mode, applied to the hemisphere with the more positive hemispheric emotional valence (HEV) as a treatment to augment the patients’ usual treatment.Results: The case reports are from 42 consecutive patients in his practice with OUD where he has given 382 treatments over 18 months, as needed. The author’s subjective clinical observations were that of the 42 patients, 26 (62%) consistently had responses to the UtPBM (as described in the case reports) that were easily observable to the patient and the author as strikingly beneficial, 8 (19%) had helpful, but not remarkable responses, and 8 (19%) had no noticeable response. These 3 characterizations will be illustrated with clinical examples. There were no side-effects reported or observed aside from 2 women who experienced anxiety which resolved with psychotherapy.ConclusionsUsing UtPBM as an adjunctive treatment to the author’s usual in-depth psychotherapy and medication management, he found subjectively that for the majority of his patients, this treatment was a valuable, safe benefit to their treatment for OUD.